BRIEF-Pdl Biopharma qtrly loss per share $0.06
March 01, 2017 at 16:26 PM EST
* Board of directors has authorized repurchase of up to $30 million of company's common stock through march 2018
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.